Cameco (NYSE:CCJ) PT Raised to C$44.00

Cameco (NYSE:CCJGet Rating) (TSE:CCO) had its target price increased by equities research analysts at Canaccord Genuity Group from C$37.00 to C$44.00 in a report released on Friday, The Fly reports. The brokerage currently has a “buy” rating on the basic materials company’s stock.

A number of other brokerages have also recently commented on CCJ. CIBC began coverage on shares of Cameco in a research note on Wednesday, January 19th. They set an “outperform” rating for the company. Zacks Investment Research cut shares of Cameco from a “buy” rating to a “hold” rating in a research note on Thursday, April 14th. Raymond James raised their price target on shares of Cameco from C$40.00 to C$47.00 in a report on Wednesday. StockNews.com initiated coverage on shares of Cameco in a report on Thursday, March 31st. They issued a “sell” rating for the company. Finally, Royal Bank of Canada raised shares of Cameco from a “sector perform” rating to an “outperform” rating and set a $50.00 price target for the company in a report on Monday, April 11th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Cameco has an average rating of “Buy” and an average price target of $42.00.

CCJ traded down $0.90 during midday trading on Friday, reaching $27.39. 473,067 shares of the company’s stock were exchanged, compared to its average volume of 8,324,899. The firm has a market capitalization of $10.91 billion, a price-to-earnings ratio of -137.59 and a beta of 0.84. The company has a quick ratio of 4.19, a current ratio of 5.18 and a debt-to-equity ratio of 0.21. Cameco has a one year low of $15.34 and a one year high of $32.49. The business has a 50-day simple moving average of $26.66 and a two-hundred day simple moving average of $24.50.

Cameco (NYSE:CCJGet Rating) (TSE:CCO) last announced its quarterly earnings results on Wednesday, February 9th. The basic materials company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.07. The firm had revenue of $368.91 million during the quarter. Cameco had a negative net margin of 7.01% and a negative return on equity of 2.00%. During the same quarter in the prior year, the business earned $0.09 EPS. As a group, research analysts anticipate that Cameco will post 0.05 EPS for the current fiscal year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. AdvisorNet Financial Inc bought a new position in shares of Cameco during the first quarter worth $29,000. Bank of New Hampshire bought a new position in shares of Cameco during the first quarter worth $34,000. Cypress Capital Management LLC WY boosted its position in shares of Cameco by 663.5% during the third quarter. Cypress Capital Management LLC WY now owns 1,527 shares of the basic materials company’s stock worth $33,000 after purchasing an additional 1,327 shares in the last quarter. Sandy Cove Advisors LLC bought a new stake in Cameco in the 4th quarter valued at $38,000. Finally, First Horizon Advisors Inc. bought a new stake in Cameco in the 3rd quarter valued at $44,000. 58.26% of the stock is owned by hedge funds and other institutional investors.

Cameco Company Profile (Get Rating)

Cameco Corporation produces and sells uranium. It operates through two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

Featured Stories

The Fly logo

Analyst Recommendations for Cameco (NYSE:CCJ)

Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.